FDA
- United States
LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients
Seoul, South Korea & Cambridge, Mass., United States: LC350189 showed significant serum uric acid (sUA)-lowering effects across all dose levels.…
Read More » - World
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treat
Osaka, Japan: − If Approved, Maribavir Will Be the First and Only Treatment Indicated for Post-Transplant Cytomegalovirus (CMV) Infection in…
Read More » - Health
Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota-based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW) 2021
Saint-Prex, Switzerland & Roseville, Minn., United States: For the first time ever, Ferring and Rebiotix, a Ferring Company, will present…
Read More » - India
Nanotronics Health Donates Hundreds of Non-Invasive Ventilators for COVID-19 Relief in India, in Collaboration with Transworld Group
New York, United States & Mumbai, Maharashtra, India: Nanotronics Health, LLC, a healthcare technology company whose mission is to create…
Read More » - Business Wire
Galderma Announces Publication of Phase 2b Trial Results Demonstrating the Rapid and Long-lasting Benefits of Nemolizumab in Clinical Trial Subjects With Uncontrolled Atopic Dermatitis
Atopic dermatitis is the most common type of eczema. Moderate to severe atopic dermatitis is a chronic and incurable condition,…
Read More » - Health
Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade
Osaka, Japan: Company Aiming for Mid-Single-Digit Revenue CAGR Over Next Decade Amounting to JPY5 Trillion ($47 Billion) by FY20301 Wave…
Read More » - Business
Philip Morris International Announces U.S. Food and Drug Administration Authorization of IQOS 3 for Sale in the United States
New York, United States: The U.S. Food and Drug Administration (FDA) today confirmed that IQOS 3, Philip Morris International’s electrically heated…
Read More » - India
Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection; Phase 1 Clinical Trial of RP7214 Set to Begin Early December 2020
LA CHAUX DU FONDS, Switzerland: Rhizen announces the approval of its IND by USFDA for its oral DHODH inhibitor for…
Read More » - World
LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025, a SSAO/VAP-1 Inhibitor
Nanjing, China & Seoul, Korea: LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co.…
Read More » - Technology
ActiFiber – Natural Sugar Control Made Easy
Bengaluru, Karnataka, India: ActiFiber Natural Sugar Control is a new innovative product from Essens Wellness. It is 100% Plant Origin, Soluble Fiber…
Read More » - Health
NTHU Researchers Discover New Gastric Cancer Biomarkers for Tailored Therapy
Professor Wang Wen-ching (left) of the Institute of Molecular and Cellular Biology and Dr. Tseng Linlu researching a new treatment…
Read More » - World
Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients
LACHEN, Switzerland: Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing…
Read More » - Technology
Making India Safe: Tushti Launches Range of Oximeters and Infrared Thermometers
New Delhi, Delhi, India: Recognizing the indispensable need for finger-tip pulse oximeters and infrared/Non-contact thermometers amid the COVID-19 pandemic, Tushti…
Read More »